MIR1343
gene geneOn this page
Also known as hsa-mir-1343
Summary
MIR1343 (microRNA 1343, HGNC:41902) is a microRNA gene on chromosome 11p13.
microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.
Source: NCBI Gene 100616437 — RefSeq curated summary.
At a glance
- Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:41902 |
| Approved symbol | MIR1343 |
| Name | microRNA 1343 |
| Location | 11p13 |
| Locus type | RNA, micro |
| Status | Approved |
| Aliases | hsa-mir-1343 |
| Ensembl gene | ENSG00000251862 |
| Ensembl biotype | miRNA |
| Entrez | 100616437 |
| RNAcentral | URS000075B394 — miRNA, 84 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 miRNA
ENST00000516053
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000516053 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002088330 | 34941837 | 34941920 |
Expression profiles
Bgee: expression breadth broad, 62 present calls, max score 88.55.
Top tissues by expression
62 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 88.55 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 85.35 | gold quality |
| adrenal tissue | UBERON:0018303 | 79.63 | gold quality |
| blood | UBERON:0000178 | 79.20 | gold quality |
| liver | UBERON:0002107 | 75.14 | gold quality |
| gastrocnemius | UBERON:0001388 | 74.14 | gold quality |
| prefrontal cortex | UBERON:0000451 | 73.00 | gold quality |
| stomach | UBERON:0000945 | 70.18 | gold quality |
| adrenal gland | UBERON:0002369 | 70.09 | gold quality |
| tibial artery | UBERON:0007610 | 69.91 | gold quality |
| body of pancreas | UBERON:0001150 | 68.57 | gold quality |
| heart left ventricle | UBERON:0002084 | 68.17 | gold quality |
| heart | UBERON:0000948 | 67.82 | gold quality |
| body of stomach | UBERON:0001161 | 67.73 | gold quality |
| left adrenal gland | UBERON:0001234 | 67.62 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 67.61 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 67.60 | gold quality |
| hypothalamus | UBERON:0001898 | 66.77 | gold quality |
| ascending aorta | UBERON:0001496 | 66.64 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 66.46 | gold quality |
| endometrium | UBERON:0001295 | 66.34 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 66.00 | gold quality |
| left ovary | UBERON:0002119 | 65.90 | gold quality |
| fundus of stomach | UBERON:0001160 | 65.52 | gold quality |
| corpus callosum | UBERON:0002336 | 65.38 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 65.33 | gold quality |
| putamen | UBERON:0001874 | 64.81 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 64.39 | gold quality |
| skin of abdomen | UBERON:0001416 | 64.30 | gold quality |
| omental fat pad | UBERON:0010414 | 64.00 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.47 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 8)
- MiR-1343 reduces the expression of both TGF-beta receptor 1 and 2 by directly targeting their 3’-UTRs. (PMID:26542979)
- Novel long non-coding RNA LINC02323 promotes epithelial-mesenchymal transition and metastasis via sponging miR-1343-3p in lung adenocarcinoma. (PMID:32643848)
- Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343-3p to upregulate RAF1 expression. (PMID:32678071)
- Novel long noncoding RNA LINC02323 promotes cell growth and migration of ovarian cancer via TGF-beta receptor 1 by miR-1343-3p. (PMID:33247856)
- LINC01559 promotes colorectal cancer via sponging miR-1343-3p to modulate PARP1/PTEN/AKT pathway. (PMID:34329839)
- Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR-1343-3p/Bcl-3 axis through TGFbeta/Smad3/EMT signaling. (PMID:37132942)
- FTO-mediated epigenetic upregulation of LINC01559 confers cell resistance to docetaxel in breast carcinoma by suppressing miR-1343-3p. (PMID:37584416)
- CircGLIS3 promotes gastric cancer progression by regulating the miR-1343-3p/PGK1 pathway and inhibiting vimentin phosphorylation. (PMID:38459513)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.